Clinical trial
Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study
NCT06633250 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy: a Randomized Nutritional Clinical Study
- Lead sponsor
- Société des Produits Nestlé (SPN)
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 25, 2024
- Completion date
- August 31, 2026
- Enrollment
- 104 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
cow milk protein allergy